The DOI matches its Crossref record; 52 of the 52 references it cites were found in a registry or an index.
Opioids and the immune system – friend or foe
Open accessAbstract
Systemically administered opioids are among the most powerful analgesics for treating severe pain. Several negative side effects (respiratory depression, addiction, nausea and confusion) and the risk of opioid‐induced hyperalgesia accompany opioid administration. One other side effect is the potential of opioids to suppress the immune response and thereby to increase the vulnerability to infections. The link between opioids and immunosuppression has been investigated both in vitro and in vivo as well as in patients. However, the results are inconsistent: Exogenous opioids such as morphine and fentanyl have been found to impair the function of macrophages, natural killer cells and T‐cells and to weaken the gut barrier in vitro and in animal studies. In epidemiological studies, high doses and the initiation of opioid therapy for non‐malignant pain have been correlated with a higher risk of infectious diseases such as pneumonia. However clear randomized controlled studies are missing. Furthermore, immune cells including neutrophils, macrophages and T‐cells have been shown to secrete endogenous opioid peptides, which then bind to peripheral opioid receptors to relieve inflammatory and neuropathic pain. In addition to cytokines, hormones and bacterial products, the release of opioid peptides is stimulated by the application of exogenous opioids. In summary, there is a reciprocal interaction between the immune system and endogenous as well as exogenous opioids. Further to the existing epidemiological studies, controlled clinical studies are needed in the future to elucidate the role of the opioid–immune system interaction in patients and to determine its clinical relevance. Linked Articles: This article is part of a themed section on Emerging Areas of Opioid Pharmacology. To view the other articles in this section visit http://onlinelibrary.wiley.com/doi/10.1111/bph.v175.14/issuetoc
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Dendritic cells and the control of immunity
Banchereau, J., & Steinman, R. M. (1998) · Nature · doi:10.1038/32588 · Cited by 14,336
CDC Guideline for Prescribing Opioids for Chronic Pain—United States, 2016
Dowell, D., Haegerich, T. M., & Chou, R. (2016) · JAMA · doi:10.1001/jama.2016.1464 · Cited by 5,161
Southan, C., Sharman, J. L., Benson, H. E., Faccenda, E., Pawson, A. J., Alexander, S. P. H., Buneman, O. P., Davenport, A. P., McGrath, J. C., Peters, J. A., et al. (2016) · Nucleic Acids Research · doi:10.1093/nar/gkv1037 · Cited by 1,035
The Concise Guide to PHARMACOLOGY 2015/16: G protein‐coupled receptors
Alexander, S. P., Davenport, A. P., Kelly, E., Marrion, N., Peters, J. A., Benson, H. E., Faccenda, E., Pawson, A. J., Sharman, J. L., Southan, C., et al. (2015) · British Journal of Pharmacology · doi:10.1111/bph.13348 · Cited by 851
The Concise Guide to PHARMACOLOGY 2015/16: Enzymes
Alexander, S. P., Fabbro, D., Kelly, E., Marrion, N., Peters, J. A., Benson, H. E., Faccenda, E., Pawson, A. J., Sharman, J. L., Southan, C., et al. (2015) · British Journal of Pharmacology · doi:10.1111/bph.13354 · Cited by 604
Opioid Therapy and Immunosuppression: A Review
Vallejo, R., de Leon-Casasola, O., & Benyamin, R. (2004) · American Journal of Therapeutics · doi:10.1097/01.mjt.0000132250.95650.85 · Cited by 386
Roy, S., Ninkovic, J., Banerjee, S., Charboneau, R. G., Das, S., Dutta, R., Kirchner, V. A., Koodie, L., Ma, J., Meng, J., et al. (2011) · Journal of Neuroimmune Pharmacology · doi:10.1007/s11481-011-9292-5 · Cited by 309
Banerjee, S., Sindberg, G., Wang, F., Meng, J., Sharma, U., Zhang, L., Dauer, P., Chen, C., Dalluge, J., Johnson, T., et al. (2016) · Mucosal Immunology · doi:10.1038/mi.2016.9 · Cited by 266
The Concise Guide to PHARMACOLOGY 2015/16: Overview
Alexander, S. P., Kelly, E., Marrion, N., Peters, J. A., Benson, H. E., Faccenda, E., Pawson, A. J., Sharman, J. L., Southan, C., Buneman, O. P., et al. (2015) · British Journal of Pharmacology · doi:10.1111/bph.13347 · Cited by 230
Beilin, B., Shavit, Y., Hart, J., Mordashov, B., Cohn, S., Notti, I., & Bessler, H. (1996) · Anesthesia & Analgesia · doi:10.1097/00000539-199603000-00011 · Cited by 229
Meng, J., Yu, H., Ma, J., Wang, J., Banerjee, S., Charboneau, R., Barke, R. A., & Roy, S. (2013) · PLoS ONE · doi:10.1371/journal.pone.0054040 · Cited by 212
Antinociceptive and immunosuppressive effects of opiate drugs: a structure‐related activity study
Sacerdote, P., Manfredi, B., Mantegazza, P., & Panerai, A. E. (1997) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0701138 · Cited by 211
Role of the mu-opioid receptor in opioid modulation of immune function
Ninković, J., & Roy, S. (2013) · Amino Acids · doi:10.1007/s00726-011-1163-0 · Cited by 196
Dublin, S., Walker, R. L., Jackson, M. L., Nelson, J. C., Weiss, N. S., Von Korff, M., & Jackson, L. A. (2011) · Journal of the American Geriatrics Society · doi:10.1111/j.1532-5415.2011.03586.x · Cited by 184
SHARP, B. M., KEANE, W. F., SUH, H. J., GEKKER, G., TSUKAYAMA, D., & PETERSON, P. K. (1985) · Endocrinology · doi:10.1210/endo-117-2-793 · Cited by 178
The Concise Guide to PHARMACOLOGY 2015/16: Catalytic receptors
Alexander, S. P., Fabbro, D., Kelly, E., Marrion, N., Peters, J. A., Benson, H. E., Faccenda, E., Pawson, A. J., Sharman, J. L., Southan, C., et al. (2015) · British Journal of Pharmacology · doi:10.1111/bph.13353 · Cited by 159
Adoptive transfer of M2 macrophages reduces neuropathic pain via opioid peptides
Pannell, M., Łabuz, D., Celik, M. Ö., Keye, J., Batra, A., Siegmund, B., & Machelska, H. (2016) · Journal of Neuroinflammation · doi:10.1186/s12974-016-0735-z · Cited by 137
The Concise Guide to PHARMACOLOGY 2015/16: Ligand‐gated ion channels
Alexander, S. P. H., Peters, J. A., Kelly, E., Marrion, N. V., Benson, H. E., Faccenda, E., Pawson, A. J., Sharman, J. L., Southan, C., Davies, J. A., et al. (2015) · British Journal of Pharmacology · doi:10.1111/bph.13350 · Cited by 136
Chronic morphine use does not induce peripheral tolerance in a rat model of inflammatory pain.
Zöllner, C., Mousa, S., Fischer, O., Rittner, H., Shaqura, M., Brack, A., Shakibaei, M., Binder, W., Urban, F., Stein, C., et al. (2008) · Journal of Clinical Investigation · doi:10.1172/jci25911 · Cited by 130
Self-citationImmune cell–derived opioids protect against neuropathic pain in mice
Łabuz, D., Schmidt, Y., Schreiter, A., Rittner, H. L., Mousa, S. A., & Machelska, H. (2009) · Journal of Clinical Investigation · doi:10.1172/jci36246 · Cited by 120
Self-citationInhibition by opioids of phagocytosis in peritoneal macrophages
Casellas, A. M., Guardiola, H., & Renaud, F. L. (1991) · Neuropeptides · doi:10.1016/0143-4179(91)90161-b · Cited by 107
Rittner, H. L., Hackel, D., Voigt, P., Mousa, S. A., Stolz, A., Łabuz, D., Schäfer, M., Schäfer, M., Stein, C., & Brack, A. (2009) · PLoS Pathogens · doi:10.1371/journal.ppat.1000362 · Cited by 91
Self-citationvon Ritter, C., Sekizuka, E., Grisham, M. B., & Granger, D. N. (1988) · Gastroenterology · doi:10.1016/s0016-5085(88)80011-8 · Cited by 89
Łabuz, D., Berger, S., Mousa, S. A., Zöllner, C., Rittner, H. L., Shaqura, M. A., Segovia‐Silvestre, T., Przewłocka, B., Stein, C., & Machelska, H. (2006) · Journal of Neuroscience · doi:10.1523/jneurosci.4349-05.2006 · Cited by 87
Self-citationBrack, A., Rittner, H. L., Machelska, H., Shaqura, M. A., Mousa, S. A., Łabuz, D., Zöllner, C., Schäfer, M., & Stein, C. (2004) · Pain · doi:10.1016/j.pain.2003.12.008 · Cited by 86
Self-citationT lymphocytes containing β-endorphin ameliorate mechanical hypersensitivity following nerve injury
Łabuz, D., Schreiter, A., Schmidt, Y., Brack, A., & Machelska, H. (2010) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2010.04.001 · Cited by 85
Wiese, A. D., Griffin, M. R., Stein, C., Mitchel, E. F., & Grijalva, C. G. (2015) · Arthritis & Rheumatology · doi:10.1002/art.39462 · Cited by 81
Immune cell–derived opioids protect against neuropathic pain in mice
Łabuz, D., Schmidt, Y., Schreiter, A., Rittner, H. L., Mousa, S. A., & Machelska, H. (2009) · Journal of Clinical Investigation · doi:10.1172/jci36246c1 · Cited by 80
Self-citationLeukocyte opioid receptors mediate analgesia via Ca2+-regulated release of opioid peptides
Celik, M. Ö., Łabuz, D., Henning, K., Busch-Dienstfertig, M., Gavériaux‐Ruff, C., Kieffer, B. L., Zimmer, A., & Machelska, H. (2016) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2016.04.018 · Cited by 76
Häuser, W., Bock, F., Engeser, P., Hege-Scheuing, G., Hüppe, M., Lindena, G., Maier, C., Norda, H., Radbruch, L., Sabatowski, R., et al. (2015) · Der Schmerz · doi:10.1007/s00482-014-1463-x · Cited by 74
Sauer, R., Hackel, D., Morschel, L., Sahlbach, H., Wang, Y., Mousa, S. A., Roewer, N., Brack, A., & Rittner, H. L. (2014) · Molecular Pain · doi:10.1186/1744-8069-10-10 · Cited by 71
Self-citationEndogenous Opioid-Mediated Analgesia Is Dependent on Adaptive T Cell Response in Mice
Boué, J., Blanpied, C., Brousset, P., et al. (2011) · The Journal of Immunology · doi:10.4049/jimmunol.1003335 · Cited by 68
Involvement of Central μ- but Not δ- or κ-Opioid Receptors in Immunomodulation
Nelson, C. J., Schneider, G. M., & Lysle, D. T. (2000) · Brain Behavior and Immunity · doi:10.1006/brbi.1999.0575 · Cited by 65
Endogenous analgesia mediated by CD4+ T lymphocytes is dependent on enkephalins in mice
Basso, L., Boué, J., Mahiddine, K., Blanpied, C., Robiou-du-Pont, S., Vergnolle, N., Deraison, C., & Dietrich, G. (2016) · Journal of Neuroinflammation · doi:10.1186/s12974-016-0591-x · Cited by 64
Suppression of natural killer cell activity by morphine is mediated by the nucleus accumbens shell
Saurer, T. B., Carrigan, K. A., Ijames, S. G., & Lysle, D. T. (2005) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2005.11.009 · Cited by 61
Immune conditions associated with CD4+ T effector-induced opioid release and analgesia
Boué, J., Blanpied, C., Cabral, M. D., Pelletier, L., Vergnolle, N., & Dietrich, G. (2011) · Pain · doi:10.1016/j.pain.2011.11.013 · Cited by 60
Neuropeptide Y Y1 receptors mediate morphine-induced reductions of natural killer cell activity
Saurer, T. B., Ijames, S. G., & Lysle, D. T. (2006) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2006.05.002 · Cited by 59
Rittner, H. L., Łabuz, D., Richter, J. F., Brack, A., Schäfer, M., Stein, C., & Mousa, S. A. (2007) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2007.05.002 · Cited by 59
Self-citationJagla, C., Martus, P., & Stein, C. (2014) · Pain · doi:10.1016/j.pain.2014.07.011 · Cited by 59
Wang, J., Ma, J., Charboneau, R., Barke, R. A., & Roy, S. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.188680 · Cited by 58
Long, X., Li, Y., Qiu, S., Liu, J., He, L., & Peng, Y. (2016) · Translational Psychiatry · doi:10.1038/tp.2016.4 · Cited by 52
Opioid Therapy in the Treatment of Chronic Pain Conditions in Germany
Werber, A. (2015) · Pain Physician · doi:10.36076/ppj/2015.18.e323 · Cited by 49
Morphine‐Induced Degradation of the Host Defense Barrier: Role of Macrophage Injury
Bhaskaran, M. C., Reddy, K., Sharma, S., Singh, J., Radhakrishnan, N., Kapasi, A. A., & Singhal, P. C. (2001) · The Journal of Infectious Diseases · doi:10.1086/324667 · Cited by 48
Morphine Withdrawal Enhances Hepatitis C Virus Replicon Expression
Wang, C., Li, Y., Douglas, S. D., Wang, X., Metzger, D. S., Zhang, T., & Ho, W. (2005) · American Journal Of Pathology · doi:10.1016/s0002-9440(10)61220-5 · Cited by 45
Rittner, H. L., Hackel, D., Yamdeu, R.-S., Mousa, S. A., Stein, C., Schäfer, M., & Brack, A. (2009) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2009.02.007 · Cited by 38
Self-citationMolina-Martínez, L. M., González‐Espinosa, C., & Cruz, S. L. (2014) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2014.06.011 · Cited by 36
Functional and structural characterization of axonal opioid receptors as targets for analgesia
Mambretti, E. M., Kistner, K., Mayer, S., Massotte, D., Kieffer, B. L., Hoffmann, C., Reeh, P. W., Brack, A., Asan, E., & Rittner, H. L. (2016) · Molecular Pain · doi:10.1177/1744806916628734 · Cited by 29
Self-citationThe effect of enkephalins and prostaglandins on O2− release by neutrophils
Simpkins, C., Alailima, S. T., Tate, E. A., et al. (1986) · Journal of Surgical Research · doi:10.1016/0022-4804(86)90090-9 · Cited by 28
MicroRNA-873 Inhibits Morphine-Induced Macrophage Apoptosis by Elevating A20 Expression
Li, M., Yu, J.-H., Yu, S., Chi, Y.-Y., & Xiang, Y.-B. (2015) · Pain Medicine · doi:10.1111/pme.12784 · Cited by 25
Ileal Mucosal Response to Bacterial Toxin Challenge
Harari, Y., Weisbrodt, N. W., & Moody, F. G. (2000) · doi:10.1097/00005373-200008000-00019 · Cited by 23
Menzebach, A., Hirsch, J., Nöst, R., et al. (2004) · AINS - Anästhesiologie · Intensivmedizin · Notfallmedizin · Schmerztherapie · doi:10.1055/s-2004-814389 · Cited by 18
Altered subcellular signaling in murine peritoneal macrophages upon chronic morphine exposure
Lugo-Chinchilla, A. M., Báez, D., Vélez, M., et al. (2006) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2006.04.007 · Cited by 15
Cited by
Cryan, J. F., O'Riordan, K. J., Cowan, C. S. M., Sandhu, K. V., Bastiaanssen, T. F. S., Boehme, M., Codagnone, M. G., Cussotto, S., Fulling, C., Golubeva, A. V., et al. (2019) · Physiological Reviews · doi:10.1152/physrev.00018.2018 · Cited by 5,286
Ferraz, C. R., Carvalho, T. T., Manchope, M. F., Artero, N. A., Rasquel-Oliveira, F. S., Fattori, V., Casagrande, R., & Verri, W. A. (2020) · Molecules · doi:10.3390/molecules25030762 · Cited by 349
Wong, C. K., McLean, B. A., Baggio, L. L., Koehler, J. A., Hammoud, R., Rittig, N., Yabut, J. M., Seeley, R. J., Brown, T. J., & Drucker, D. J. (2024) · Cell Metabolism · doi:10.1016/j.cmet.2023.11.009 · Cited by 304
The role of opioid receptors in immune system function
Eisenstein, T. K. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.02904 · Cited by 286
Shanthanna, H., Strand, N. H., Provenzano, D. A., Lobo, C. A., Eldabe, S., Bhatia, A., Wegener, J., Curtis, K., Cohen, S. P., & Narouze, S. (2020) · Anaesthesia · doi:10.1111/anae.15076 · Cited by 218
Metadata
- Authors
- Plein, L. M., & Rittner, H. L.
- Venue
- British Journal of Pharmacology
- Publisher
- Wiley
- Published
- 2017-03-23
- Volume
- 175
- Issue
- 14
- Pages
- 2717-2725
- ISSN
- 0007-1188 (ISSN-L)
- 1476-5381
- OpenAlex
- W2587845606
- Cited by
- 481
- References
- 52
- FWCI
- 18.08
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.